Trials / Recruiting
RecruitingNCT06727370
Cognitive Screening in Lung Cancer Patients
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 200 (estimated)
- Sponsor
- European Institute of Oncology · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to investigate the occurrence of cancer and adjuvant therapy-related cognitive impairment in patients with both NSCLC and SCLC. The primary endpoint measure will be the presence of cognitive impairment during the first year after enrollment through the administration of a comprehensive neuropsychological assessment.
Conditions
Timeline
- Start date
- 2024-01-10
- Primary completion
- 2025-12-31
- Completion
- 2025-12-31
- First posted
- 2024-12-10
- Last updated
- 2024-12-10
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT06727370. Inclusion in this directory is not an endorsement.